References
- Fragoso YD, Paggiaro MS, Mastromauro R, Jacondino Gda S, Wilson HM. Literature systematic review on the ophthalmological side effects of interferons. Arq Bras Oftalmol. 2011 Jul-Aug;74(4):306–310. doi:10.1590/S0004-27492011000400017.
- Rentiya ZS, Wells M, Bae J, et al. Interferon-α-induced retinopathy in chronic hepatitis C treatment: summary, considerations, and recommendations. Graefes Arch Clin Exp Ophthalmol. 2019 Mar;257(3):447–452. doi:10.1007/s00417-018-04209-7.
- Sarraf D, Rahimy E, Fawzi AA, et al. Paracentral acute middle maculopathy: a new variant of acute macular neuroretinopathy associated with retinal capillary ischemia. JAMA Ophthalmol. 2013;131:1275–1287. doi:10.1001/jamaophthalmol.2013.4056.
- Rahimy E, Kuehlewein L, Sadda SR, Sarraf D. Paracentral acute middle maculopathy: what we knew then and what we know now. Retina. 2015;35:1921–1930. doi:10.1097/IAE.0000000000000785.
- Kontny U, Franzen S, Behrends U, et al. Diagnosis and treatment of nasopharyngeal carcinoma in children and adolescents - recommendations of the GPOH-NPC study group. Klin Padiatr. 2016 Apr;228(3):105–112. doi:10.1055/s-0041-111180.
- Jain K, Lam WC, Waheeb S, Thai Q, Heathcote J. Retinopathy in chronic hepatitis C patients during interferon treatment with ribavirin. Br J Ophthalmol. 2001 Oct;85(10):1171–1173. doi:10.1136/bjo.85.10.1171.
- Xue JH, Zhu HH, Wang J, Chen Z. Interferon-associated retinopathy risk in patients with diabetes and hypertensive hepatitis C. World J Gastroenterol. 2014;20(23):7505–7513. doi:10.3748/wjg.v20.i23.7505.
- Gaetani L, Menduno PS, Cometa F, et al. Retinopathy during interferon-β treatment for multiple sclerosis: case report and review of the literature. J Neurol. 2016 Mar;263(3):422–427. doi:10.1007/s00415-015-7879-0.
- Chen X, Rahimy E, Sergott RC, et al. Spectrum of retinal vascular diseases associated with paracentral acute middle maculopathy. Am J Ophthalmol. 2015;160:26–34. doi:10.1016/j.ajo.2015.04.004.
- Nemiroff J, Kuehlewein L, Rahimy E, et al. Assessing deep retinal capillary ischemia in paracentral acute middle maculopathy by optical coherence tomography angiography. Am J Ophthalmol. 2015;162:121–132. doi:10.1016/j.ajo.2015.10.026.
- Sridhar J, Shahlaee A, Rahimy E, et al. Optical coherence tomography angiography and en face optical coherence tomography features of paracentral acute middle maculopathy. Am J Ophthalmol. 2015;160:1259–1268. doi:10.1016/j.ajo.2015.09.016.
- Casalino G, Coppola M, Earley O, Contieri F, Bandello F, Chakravarthy U. Paracentral acute middle maculopathy as a cause of unexplained visual loss in central retinal vein occlusion. Saudi J Ophthalmol. 2019 Apr-Jun;33(2):168–171. doi:10.1016/j.sjopt.2018.07.005.
- Medhat E, Esmat G, Hamza E, et al. Ophthalmological side effects of interferon therapy of chronic hepatitis C. Hepatobiliary Surg Nutr. 2016;5(3):209–216. doi:10.21037/hbsn.2015.12.14.
- Bakri SJ, Swanson JW. Asymptomatic peripheral retinal hemorrhages as a manifestation of interferon beta 1a retinopathy. Semin Ophthalmol. 2015 Jan;30(1):56–57. doi:10.3109/08820538.2013.814693.
- Hayasaka S, Nagaki Y, Matsumoto M, Sato S. Interferon associated retinopathy. Br J Ophthalmol. 1998;82(3):323–325. doi:10.1136/bjo.82.3.323.